Disinfectant & Biocide

U.S. FDA's Temporary Hand Sanitizer Policy (2020, Withdrawn)

Updated on

U.S. FDA HAND SANITIZER POLICY | HISTORICAL UPDATE

During the early COVID-19 pandemic, shortages of alcohol-based hand sanitizers affected consumers and healthcare professionals in the United States. In March 2020, FDA introduced a temporary enforcement policy to help expand supply, subject to specified formulation, quality, labelling and registration conditions.

March 2020 policy      Alcohol-based hand sanitizers      Policy subsequently withdrawn

Policy Status: Withdrawn

FDA withdrew the temporary hand sanitizer guidances effective December 31, 2021. Firms operating under those policies had to cease production by that date and cease distribution of remaining products manufactured under the policies by March 31, 2022. The sections below describe the March 2020 policy for historical reference. See FDA's withdrawal Q&A for the applicable transition details.

Quick Navigation

Explore the background and conditions of the historical policy.

Hand Hygiene and the U.S. Regulatory Background

Following the COVID-19 outbreak and the World Health Organization's pandemic declaration, the United States experienced increased demand for products supporting hand hygiene. The original March 2020 report highlighted handwashing with soap and water for at least 20 seconds, particularly after using the bathroom, before eating, and after coughing, sneezing or blowing the nose. Where soap and water were unavailable, CDC recommended an alcohol-based hand sanitizer containing at least 60% alcohol.

In the United States, hand sanitizers are regulated by FDA as over-the-counter (OTC) drugs. The regulatory framework addresses active ingredient concentrations, active and inactive ingredient purity, and current good manufacturing practice (CGMP), including 21 CFR parts 210 and 211.

For consumer antiseptic rubs, FDA's 2019 final rule deferred final safety and effectiveness determinations for three active ingredients, as explained in its Consumer Antiseptic Rub Final Rule Q&A.

Conditions Described in the March 2020 Temporary Policy

As recorded in FDA's COVID-19 response chronology, FDA announced guidance on March 20, 2020 to help boost supplies of alcohol-based hand sanitizers. The policy described circumstances in which FDA did not intend to take enforcement action against certain firms preparing ethanol- or isopropyl alcohol-based products during the public health emergency.

The original article summarised the following conditions:

  • Formulation: follow the specified formulation set out below.

  • Raw materials: use United States Pharmacopeia (USP) grade ingredients, with USP or Food Chemical Codex (FCC) grade ethanol.

  • Alcohol concentration and testing: maintain controls to achieve 80% ethanol or 75% isopropyl alcohol and analyse each batch before distribution.

  • Sanitary conditions: prevent insanitary conditions under section 501(a)(2)(A) of the FD&C Act (21 U.S.C. 351(a)(2)(A)).

  • Labelling: meet the labelling conditions set out in the guidance.

  • Establishment registration: register the facility with FDA through the Drug Registration and Listing System.

  • Adverse events: maintain a process for receiving adverse event reports and submit reports received to FDA.

Historical Formulation Requirements

The March 2020 article described a formulation using the ingredients below, consistent with WHO-recommended handrub formulations. Percentages refer to the final product concentration by volume (v/v). Select one of the two alcohol options; glycerol, hydrogen peroxide and water complete the formulation.

IngredientFinal ConcentrationSpecification Described in the Article
Alcohol option 1: ethanol80% v/vUSP or FCC grade, in an aqueous solution denatured in accordance with Alcohol and Tobacco Tax and Trade Bureau regulations in 27 CFR part 20.
Alcohol option 2: isopropyl alcohol75% v/vUSP grade, in an aqueous solution; an alternative to the ethanol option.
Glycerol1.45% v/vUSP grade.
Hydrogen peroxide0.125% v/vUSP grade.
WaterAs required for the final formulationSterile distilled water or boiled, cooled water.

Historical concentration note: the original article also cited the 1994 tentative final monograph (TFM) ranges of 60–95% v/v ethanol in a denatured aqueous solution under 27 CFR part 20 and 70–91.3% v/v isopropyl alcohol. These broader ranges are distinct from the specific 80% ethanol or 75% isopropyl alcohol formulations described above.

Separate Temporary Policy for Compounding

FDA also issued a separate temporary policy for certain alcohol-based hand sanitizers compounded by pharmacists in state-licensed pharmacies or federal facilities, and registered outsourcing facilities. As reported in the original article, that temporary policy did not require a patient-specific prescription.

The compounding guidance was among the documents subsequently withdrawn. Its title and withdrawal are recorded in the official Federal Register notice.

How REACH24H Can Help

For current U.S. market-entry projects, REACH24H provides FDA hand sanitizer registration and compliance services, including:

  • FDA establishment registration.

  • National Drug Code (NDC) application and product listing.

  • Label review, listing updates and re-registration.

Review Your U.S. Hand Sanitizer Compliance

Discuss establishment registration, product listing and label review for your current hand sanitizer project with REACH24H.

Recommended Reading

Official References

REACH24H Disinfectant & Biocide Compliance Team

Written by

REACH24H Disinfectant & Biocide Compliance Team

REACH24H

The disinfectant and biocide team at REACH24H delivers one-stop regulatory compliance services across China, the EU, the US, South Korea and Canada. With 30+ toxicologists and biocidal regulatory experts, we have served 1,000+ companies, providing support for active substance approval, product registration and authorisation, testing coordination, risk assessment and ongoing compliance.

Newsletter Subscription

Sign up to receive event invitations, expert insights, timely news alerts, and other updates.

SUBSCRIBE

Contact Us

REACH24H USA

+1 703 596 8055

REACH24H EU

+353 1 8899 951

REACH24H UK

+44 782 7193124

REACH24H China

+86 571 87103805

REACH24H Korea

+82 2 62451610

REACH24H Japan

+03 5005 0662

REACH24H Singapore

Events

Compliance Strategies for Biocidal Products in Europe, America, China, and South Korea
Full Image

We use cookies to ensure that you have the best browsing experience on our website, analyze the relevance between you and our content, and further understand our privacy policy.